• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Aug15
CEL-SCI released FY2025 9 Months earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -6.9458
03:00
CEL-SCI released FY2025 Q3 earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -1.3647
03:00
Jul14
CEL-SCI Completes $5.7 Million Market Offering
20:05
CEL-SCI Partners with Saudi Pharma Firm to Advance Multikine
10:45
Jul11
CEL-SCI Announces $5.7 Million Market Stock Offering
16:16
Jul3
CEL-SCI Files for Up to $100 Million Shelf Offering
20:12

Schedules & Filings

Schedules
Filings
Aug14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.665 M, EPS -1.3647

May20
Reverse Stock Split(EST)

1-for-30 Reverse Stock Split

May14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.572 M, EPS -2.3325

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AFJK
88.500
+1,006.25%
+80.500
OCG
10.270
+291.98%
+7.650
NCPL
1.400
+112.48%
+0.741
LGHL
8.050
+85.91%
+3.720
JXG
8.630
+67.90%
+3.490
ATMVR
1.060
+49.49%
+0.351
DBI
7.200
+48.45%
+2.350
HSPO
17.500
+42.28%
+5.200
CYPH
1.620
+39.66%
+0.460
ALEX
20.850
+37.71%
+5.710
View More